Tuksin Jearanaiwitayakul
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Human dermal fibroblast-derived factors from sequential DENV-2 and ZIKV coinfection drive dendritic cell maturation and antiviral responses.
Journal: Virology
Published: March 01, 2026
Unique molecular profiling of monocyte responses to a high dose of DENV-NS1 reflected the effect of NS1 on hemostasis.
Journal: Medical microbiology and immunology
Published: October 05, 2025
A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.
Journal: Viruses
Published: February 11, 2025
Transcriptomic analysis of DENV-2-infected human dermal fibroblasts identified potential mechanisms that suppressed ZIKV replication during sequential coinfection.
Journal: Virology journal
Published: February 07, 2025
Transcriptome Analysis of Monocytes Treated With Dengue Virus Nonstructural Protein 1 Revealed a Shift in Transcripts Involved in Self-Propagated Proinflammation and Antiviral Responses.
Journal: The Journal of infectious diseases
Published: December 19, 2024
Intranasal Administration of Bivalent RBD Nanoparticles Elicits Strong Systemic Responses That Effectively Block Distal Dissemination of COVID-19.
Journal: Microbiology and immunology
Published: October 28, 2024
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
Journal: Vaccine
Published: March 09, 2024
Responses of primary human nasal epithelial cells to COVID-19 vaccine candidate.
Journal: Asian Pacific journal of allergy and immunology
Published: January 06, 2024
The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine.
Journal: Vaccines
Published: June 25, 2023
A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells.
Journal: Vaccine
Published: July 28, 2022
Mice immunized with trimethyl chitosan nanoparticles containing DENV-2 envelope domain III elicit neutralizing antibodies with undetectable antibody-dependent enhancement activity.
Journal: The Journal of general virology
Published: July 14, 2022
Last Updated: 09/26/2026